Kinetic filtering of [18F]Fluorothymidine in positron emission tomography studies
暂无分享,去创建一个
F. Turkheimer | S. Shousha | K. Gray | J. Stebbing | E. Aboagye | H. Wasan | L. Rosso | A. Al-nahhas | L. Kenny | R. Coombes | K. Contractor | A. Al-Nahhas
[1] Alexander Hammers,et al. Functional and structural synergy for resolution recovery and partial volume correction in brain PET , 2009, NeuroImage.
[2] Klaus Wienhard,et al. Glioma Proliferation as Assessed by 3‘-Fluoro-3’-Deoxy-l-Thymidine Positron Emission Tomography in Patients with Newly Diagnosed High-Grade Glioma , 2008, Clinical Cancer Research.
[3] Shankar Vallabhajosula,et al. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization. , 2007, Seminars in nuclear medicine.
[4] Falko Fend,et al. Early Response Assessment Using 3′-Deoxy-3′-[18F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma , 2007, Clinical Cancer Research.
[5] P. Hoskin,et al. Positron emission tomography in oncology: a review. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).
[6] Eric O. Aboagye,et al. Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[7] F. Turkheimer,et al. Reference and target region modeling of [11C]-(R)-PK11195 brain studies. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] J. Mercer. Molecular imaging agents for clinical positron emission tomography in oncology other than fluorodeoxyglucose (FDG): applications, limitations and potential. , 2007, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[9] C. Tsoumpas,et al. STIR: software for tomographic image reconstruction release 2 , 2012, 2006 IEEE Nuclear Science Symposium Conference Record.
[10] T. Mattfeldt,et al. Molecular imaging of proliferation in malignant lymphoma. , 2006, Cancer research.
[11] David Dagan Feng,et al. Segmentation of VOI From Multidimensional Dynamic PET Images by Integrating Spatial and Temporal Features , 2006, IEEE Transactions on Information Technology in Biomedicine.
[12] F. Pedersen,et al. Principal component analysis of dynamic positron emission tomography images , 1994, European Journal of Nuclear Medicine.
[13] S. Shousha,et al. Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods. , 2005, Cancer research.
[14] Michael E. Phelps,et al. Usefulness of 3′-[F-18]Fluoro-3′-deoxythymidine with Positron Emission Tomography in Predicting Breast Cancer Response to Therapy , 2005, Molecular Imaging and Biology.
[15] P. Price,et al. Use of Positron Emission Tomography in Anticancer Drug Development , 2003, Investigational New Drugs.
[16] Torsten Mattfeldt,et al. Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] E. Reiman,et al. Clustering huge data sets for parametric PET imaging. , 2003, Bio Systems.
[18] Donald L Weaver,et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] G. Cheon,et al. Blind separation of cardiac components and extraction of input function from H(2)(15)O dynamic myocardial PET using independent component analysis. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[20] V. Pike,et al. An improved synthesis of 3′-DEOXY-3′-[18F]fluorothymidine ([18F]FLT) and the fate of the precursor, 2, 3′-anhydro-5′-O-(4, 4′-dimethoxytrityl)-thymidine , 2001 .
[21] M. Christian,et al. [New guidelines to evaluate the response to treatment in solid tumors]. , 2000, Bulletin du cancer.
[22] M. van Glabbeke,et al. New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.
[23] G Lucignani,et al. Estimation of Component and Parameter Distributions in Spectral Analysis , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[24] Otto Muzik,et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography , 1998, Nature Medicine.
[25] Chin-Tu Chen,et al. Classification of Dynamic PET Images Using a Priori Kinetic Factors , 1998 .
[26] F. Turkheimer,et al. The Use of Spectral Analysis to Determine Regional Cerebral Glucose Utilization with Positron Emission Tomography and [18F]Fluorodeoxyglucose: Theory, Implementation, and Optimization Procedures , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[27] H. Malcolm Hudson,et al. Accelerated image reconstruction using ordered subsets of projection data , 1994, IEEE Trans. Medical Imaging.
[28] T. Jones,et al. Spectral Analysis of Dynamic PET Studies , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[29] L. Shepp,et al. Maximum Likelihood Reconstruction for Emission Tomography , 1983, IEEE Transactions on Medical Imaging.
[30] P. Mahalanobis. On the generalized distance in statistics , 1936 .
[31] D. DuBois,et al. A formula to estimate the approximate surface area if height and weight be known , 1989 .
[32] D. D. Bois,et al. CLINICAL CALORIMETRY: TENTH PAPER A FORMULA TO ESTIMATE THE APPROXIMATE SURFACE AREA IF HEIGHT AND WEIGHT BE KNOWN , 1916 .